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Abstract
Precision in redox signaling is attained through posttranslational protein modifications such as oxidation of protein
thiols. The peroxidase peroxiredoxin 1 (PRDX1) regulates signal transduction through changes in thiol oxidation of its
cysteines.We demonstrate here that PRDX1 is a binding partner for the tumor suppressive transcription factor FOXO3
that directly regulates the FOXO3 stress response. Heightened oxidative stress evokes formation of disulfide-bound
heterotrimers linking dimeric PRDX1 to monomeric FOXO3. Absence of PRDX1 enhances FOXO3 nuclear locali-
zation and transcription that are dependent on the presence of Cys31 or Cys150 within FOXO3. Notably, FOXO3-T32
phosphorylation is constitutively enhanced in thesemutants, but nuclear translocationofmutant FOXO3 is restoredwith
PI3K inhibition. Here we show that on H2O2 exposure, transcription of tumor suppressive miRNAs let-7b and let-7c is
regulated by FOXO3 or PRDX1 expression levels and that let-7c is a novel target for FOXO3. Conjointly, inhibition
of let-7microRNAs increases let-7-phenotypes in PRDX1-deficient breast cancer cells. Altogether, these data ascertain
the existence of an H2O2-sensitive PRDX1-FOXO3 signaling axis that fine tunes FOXO3 activity toward the tran-
scription of gene targets in response to oxidative stress. Antioxid. Redox Signal. 28, 62–77.
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Introduction
Appropriate cell responses to stress are necessary todecide cell fate. Recent evidence establishes protein
sulfhydryl groups as modulators of signaling events through
oxidation state changes, which impact protein interactions
and activity (15). This posttranslational calibration requires a
dynamic reversibility of the protein modification. Interest-
ingly, in contrast to (de)/phosphorylation events induced by
the interplay of protein kinases and phosphatases, protein
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sulfhydryl group oxidation to highly oxidized forms such as
sulfonic acid can be irreversible, resulting in protein degra-
dation or in the case of peroxiredoxins, a change of function.
Peroxiredoxin (PRDX) family members (typical 2-Cys:
PRDX1-4, atypical 2-Cys: PRDX5, and 1-Cys: PRDX6) are
antioxidant enzymes that reduce peroxides via catalytic
cysteine oxidation to sulfenic acid. Evidence is accumulating
that demonstrates 2-Cys PRDXs as important redox sensors
in signaling (36) through two unique features: (a) a highly
reactive catalytic cysteine that converts to a protein sulfenic
acid moiety that produces a disulfide bond with a resolving
cysteine, which can be reduced via thioredoxin to reset cat-
alytic function (22); and (b) during recycling the catalytic
cysteine of PRDX can be further oxidized, which promotes
formation of PRDX decamers that display chaperone func-
tionality, but lack peroxidase activity (36). These features
equip PRDX1 to sense and react to changes in redox sig-
naling accordingly by controlling protein-binding partners.
For example, we have recently shown heightened oxidative
stress can over-oxidize PRDX1, which causes PRDX1 to
dissociate from MKP1 as well as increase association and
activity of MKP5, thereby regulating senescence (61). A
similar mechanism has been described for PRDX1 and PTEN
(9) or MST1 (35) and for PRDX2 and ERp46 (41). Recently,
PRDXs have gained attention to act as redox relays involving
the catalytic and resolving cysteine to form disulfides with
the partnering protein to transfer oxidative equivalents. This
has been suggested for PRDX1 and ASK1 (28, 30) and most
recently, a transient PRDX2-STAT3 redox relay has been
described that resulted in STAT3 oligomerization and inac-
tivation (57).
Our studies shown here demonstrate that PRDX1 interacts
with the transcription factor FOXO3 through disulfide bonds.
The mammalian forkhead box transcription factors of the
O class (FOXOs) comprise four family members (FOXO1, 3,
4, and 6), which are highly related tumor suppressors that
provide resistance to oxidative stress, halt cell cycle progres-
sion, and control the induction of cellular apoptosis. Although
FOXOs serve as major cellular reactive oxygen species (ROS)
arbitrators (45), the mechanisms by which FOXOs sense and
integrate ROS signals to define transcriptional outcomes are
still poorly understood (17). A recent mass spectrometry
analysis indicated FOXO cysteines to be involved in protein
binding, underscoring their role for redox sensing (46). In
response to oxidative stress, FOXO proteins translocate to the
nucleus due to phosphorylation by mammalian sterile 20-like
kinase 1 (MST1) and Jun N-terminal kinase ( JNK), as well
as monoubiquitination (7). FOXO is negatively regulated
through the phosphoinositide 3-kinase (PI3K)/AKT signaling
pathway, which promotes cytoplasmic sequestration of FOXO
via AKT-induced phosphorylation and therefore causing
FOXO inactivation in many cancers (7, 62).
As cancer cells carry a higher pro-oxidant burden com-
pared to normal cells (32), we examined the role of PRDX1 in
FOXO3 function and binding under pro-oxidant conditions.
We establish that PRDX1 binds FOXO3 under H2O2 stress
and regulates FOXO3 nuclear localization and activity
through disulfide bridges involving the PRDX1 peroxidatic
C52 and resolving C173 and surprisingly C71, which has not
been previously seen. Within FOXO3, PRDX1 binding en-
gages C31 and 150, the latter of which is not conserved among
FOXO family members. Mutation of these FOXO3 cysteines
causes changes to the phosphorylation levels of AKT sub-
strate sites and heightened cytoplasmic localization that is
responsive to PI3K inhibition in comparison to FOXO3WT.
We also demonstrate for the first time that let-7c, a member
of the let-7 family widely regarded as a tumor suppres-
sor microRNA (miRNA), is a novel FOXO3 target. let-7c
and let-7b miRNAs are significantly increased by H2O2
exposure in a FOXO3- and PRDX1-dependent manner,
and inhibit breast cancer cell migration. Notably, several
‰
FIG. 1. PRDX1 binds to FOXO3 in an H2O2 dose-dependent manner and regulates FOXO3 nuclear localization.
(A) Immunoprecipitation of precleared lysate with PRDX1 or IgG antibodies found PRDX1 bound FOXO3. 293T cells
underwent serum starvation for 30min and were then treated with the 0 or 100 lM H2O2 for an additional 30min. (B and C)
293T cells were transfected with pcDNA3-FLAG-FOXO3A or EV and treated with increasing concentrations of H2O2 for
the indicated times. Before lysis, cells were washed with 20mM NEM in phosphate-buffered saline to block lysis-induced
disulfide bond formation. FLAG-labeled proteins were immunoprecipitated and detected by immunoblot with FLAG and
PRDX1 antibodies. (D and E) The percentage of 293T cells displaying nuclear FOXO3-EGFP localization was enhanced
with reduction of PRDX1; 150 or more cells analyzed per sample, p< 0.0001 (t-test). Cells infected with shPRDX1A or
control lentivirus for 48 h, followed by transfection with FOXO3-EGFP for 24 h. H2O2 was added during the last 30min. (F)
HA-PRDX reduced FLAG-FOXO3 activity when transiently cotransfected into MEF and analyzed utilizing a dual-
luciferase reporter assay. Values (mean + SE) were normalized to vehicle treatment. *p < 0.05, t-test (N = 3). (G) qPCR gene
transcription of SESN3 and P27 was increased in PRDX1-deficient 293T cells (white bars) treated with 250 lM H2O2
compared to pLKO.1 control cells (black bars) after 16 h. Values (mean + SE) were normalized to vehicle treatment.
*p < 0.05, t-test (N = 3). MEF, murine embryonic fibroblast; NEM, N-ethylmaleimide; SE, standard error.
Innovation
It is widely established that free radicals such as H2O2
cause oxidative stress and promote disease. Members of
the mammalian forkhead (FOXO) family of transcription
factors are tumor suppressors that oppose oxidative stress,
but the mechanisms by which FOXOs sense and respond
to oxidative stress are not well understood. Peroxiredoxins
are H2O2 scavenger proteins that destroy peroxides.
Herein, we show that peroxiredoxin 1 (PRDX1) directly
binds to FOXO3 in a peroxide dependent fashion, which
in turn regulates FOXO activity differently toward pro-
apoptotic and antioxidant response genes. These findings
are highly significant as they reveal an oxidative stress-
sensitive FOXO-PRDX1 signaling pathway that calibrates
FOXO responses in tumor suppression and aging toward
the regulated expression of genetic and epigenetic factors
when PRDX1 detects increased cellular peroxide levels.
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functional and mechanistic parallels exist for FOXO pro-
teins and let-7. Both mediate tumor suppression and glucose
homeostasis (60), and expression of the let-7 miRNA family
has similarly been shown to be governed by various ROS-
inducing stressors (52, 53). Importantly, loss of let-7c ex-
pression in cancer cells promotes migration and invasion
(33, 66). Taken together, these data provide compelling
evidence for an existence of a redox-specific signaling axis
comprising PRDX1, FOXO3, and let-7c miRNAs in regu-
lating oxidative stress signaling in breast cancer.
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Results
PRDX1 interacts with FOXO3 and regulates
its nuclear function
We confirmed a PRDX1 FOXO3 interaction by precipi-
tating endogenous FOXO3 bound to PRDX1 by immunoblot
(Fig. 1A and Supplementary Slide S1A; Supplementary Data
are available online at www.liebertpub.com/ars). Precipita-
tion of FLAG-FOXO3 from transfected 293T cells indicated
that PRDX1 binding was elevated following treatment with
25–500 lM H2O2 in the presence of lysis buffer containing
N-ethylmaleimide (NEM), a chemical agent that alkylates the
thiol group on cysteines, therefore reducing postlysis oxida-
tion events that might otherwise occur (Fig. 1B and Supple-
mentary Slide S1B). Interestingly, the PRDX1-FOXO3
complex displayed time-dependent binding dynamics when
transfected 293T cells were treated with 250 and 500lM
H2O2 (Fig. 1C and Supplementary Slide S1C). Maximal
PRDX1-FOXO3 oligomerization was seen at 30min, which
returned to baseline after 3 h. An assay to measure apoptosis,
cell viability, and cytotoxicity found no significant changes
in any of the three measurements, between treatment and
no treatment over a period of 3 h, suggesting that the decrease
in PRDX1-FOXO3 binding was not a result of cell death
(Supplementary Fig. S1B). Further experiments in the ab-
sence of NEM found that binding dynamics of FLAG-
FOXO3 and PRDX1 followed a U-shaped H2O2 dose curve
with maximal binding at 100lM H2O2 and complex disso-
ciation at higher concentrations (Supplementary Fig. S1A
and Supplementary Slide S1A). In addition, we could not
detect any over-oxidized PRDX1 binding to FOXO3, sug-
gesting that PRDX1 over-oxidation on its catalytic cysteine
may induce FOXO3 release (Supplementary Fig. S1A and
Supplementary Slide S1A).
To investigate if PRDX1 binding to FOXO3 has a func-
tional impact, we assessed FOXO3 nuclear translocation in
Prdx1-/- and Prdx1+/+murine embryonic fibroblasts (MEFs).
Interestingly, MEFs lacking PRDX1 displayed primarily
nuclear FOXO3 localization in contrast to wild-type MEFs
expressing PRDX1 (Supplementary Fig. S1C). Given the low
transfection efficiency of MEFs, we next utilized 293T cells
with reduced PRDX1 expression transfected with a FOXO3-
EGFP reporter construct (Fig. 1D, Supplementary Fig. S1D
and Supplementary Slide S1D). As Figure 1E shows, FOXO3
nuclear localization was significantly increased in 293T cells
harboring 90% less PRDX1, suggesting PRDX1 deterred
FOXO3nuclear translocation. Investigating the role of PRDX1
onFOXO3 function further,wenext evaluated FOXO3activity
specifically using a dual-luciferase reporter assay in Prdx1-/-
MEFs transiently transfected with FOXO3 and/or PRDX1.
As expected, PRDX1 decreased luciferase signals by 50%
(Fig. 1F). Investigating FOXO3 target gene expression by
quantitative polymerase chain reaction (qPCR) showed that
PRDX1 knockdown increased expression of several FOXO3
targets in H2O2-treated 293T cells compared to control,
where SESN3 and P27 differences were significantly en-
hanced (Fig. 1G).
PRDX1 and FOXO3 associate through disulfide bonds
2-Cys peroxiredoxins and FOXO proteins have been sug-
gested to form disulfide bonds with target proteins (46). We
explored whether covalent cysteine disulfide bridges exist
between PRDX1 and FOXO3. Five cysteines are present in
FOXO3 at positions 31, 150, 190, 362, and 622, while
PRDX1 has four cysteines at positions 52, 71, 83, and 173
(Fig. 2A). To investigate possible disulfide bridge interac-
tions between PRDX1 and FOXO3, we analyzed Prdx1+/+
and Prdx1-/- MEFs using two-color infrared (IR) antibody
detection and identified one band staining positive for both
PRDX1 and FOXO3 around 140 kDa after H2O2 treatment
(Fig. 2B), which was reduced when lysates were treated with
b-ME (Supplementary Fig. S2A). This suggests an oligo-
meric PRDX1-FOXO3 protein complex composed of mo-
nomeric FOXO3 (90 kDa) disulfide bound to dimeric PRDX1
(2· 23 kDa). To gain further insight into the specific cyste-
ines responsible for the PRDX1-FOXO3 interaction, coim-
munoprecipitations (co-IPs) of endogenous PRDX1 with
FLAG-FOXO3 single cysteine mutants revealed that loss of
FOXO3 C31 or C150 decreased binding to PRDX1 (Fig. 2C
and Supplementary Slide S2C). Conversely, coprecipitating
endogenous FOXO3 with HA-PRDX1 single cysteine mu-
tants showed that PRDX1 C52, C71, or C173 mutants de-
creased binding of endogenous FOXO3 as well (Fig. 2D and
Supplementary Slide S2D). PRDX1C71 is yet to be described
to play a role in PRDX1 protein associations. In addition,
disulfide-dependent complex formation was further analyzed
and demonstrated that, as shown in Figure 2C, while H2O2
treatment induced endogenous PRDX1 binding to wild-type
FLAG-FOXO3, and decreased PRDX1 binding to C31 and
C150 single mutants, the FLAG-FOXO3 double mutant
‰
FIG. 2. PRDX1 and FOXO3 form disulfide bonds. (A) Domain structures of FOXO3 and PRDX1 proteins. (B) A
PRDX1-FOXO3 complex was detected under nonreducing conditions in Prdx1+/+, but not Prdx1-/- MEFs, when treated
with the indicated concentrations of H2O2 for 30min by immunoblot with two-color IR antibody detection. (C) Anti-FLAG
IP of 293T cells transfected with EV or FLAG-FOXO3 (WT or single C-to-S mutants) displayed reduced PRDX1 binding to
FOXO3 C31S or C150S when treated with H2O2 for 30min by immunoblot. (D) Anti-HA IP of 293T cells transfected with
EV or HA-PRDX1 (WT or C-to-S mutants) showed reduced FOXO3 binding with PRDX1 C52S, C71S, or C173S mutants
when treated with H2O2 for 30min (*HA-PRDX1). (E) Mutation of FOXO3 cysteines reduced PRDX1 binding when
treated with 25lM H2O2 for 30min. Anti-FLAG IP of 293T cells transfected with EV or FLAG-FOXO3 (WT, C31S,
C150S, C31, 150S double mutant, or DCys mutants) was detected by immunoblot. (F) A PRDX1-FOXO3 complex was
detected in FLAG-FOXO3 WT, but not C31S or C150S mutant Anti-FLAG samples under nonreducing conditions in 293T
cells cotransfected with FLAG-FOXO3 constructs and HA-PRDX1 treated with 25lM H2O2 for 30min. (G–I) The ability
of PRDX1 to reduce FOXO3 activity was inhibited with H2O2 treatment in 293T cells in FOXO3 WT, but not C31S or
C150S mutants. Cells were transiently transfected with FOXO3 and PRDX1 constructs in a dual-luciferase assay treated
with 0–250 lM H2O2. Values (mean + SE) were normalized to FOXO3 vehicle treatment. *p< 0.05, t-test (N = 3). NES,
nuclear export sequence; NLS, nuclear localization signal.
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FIG. 3. Interdisulfides between PRDX1 and FOXO3 modulate FOXO3 subcellular localization and FOXO3
phosphorylation. (A) Thirty minutes of H2O2 treatment enhanced nuclear EGFP-FOXO3 content in WT, but not C31 or
C150 mutant constructs, 48 h following transfection in 293T cells. Percentage of cells displaying nuclear FOXO3-EGFP
localization is indicated. (B) T32 phosphorylation of FOXO3 C31S or C150S was heightened under basal conditions
compared to FOXO3 WT. 293T cells transfected with FLAG-FOXO3 (WT, C31, or C150 mutants) were treated with H2O2
and detected by immunoblot for FOXO3 Phospho-T32, FOXO3, and Actin. Phospho-T32 signals were normalized to total
FOXO3. Values represent mean +SD normalized to WT 0 lM H2O2. *p < 0.05 (N = 3). (C) PI3K inhibition with 20 lM
LY294002 enhanced nuclear FOXO3-EGFP WT, C1S, or C2S mutants in transiently transfected 293T cells after 24 h.
Values represent mean + SE (N = 3) with 150–400 cells counted per sample by fluorescence microscopy. Experiment was
repeated twice. (D) Representative pictures of (C).
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(C31,150S), and the quintuple cysteine to serine mutant
FLAG-FOXO3 (CDS) showed no PRDX1 binding (Fig. 2E
and Supplementary Slide S2E). To further examine the im-
portance of FOXO3 C31 and C150 in oligomeric formation,
we expressed FLAG-FOXO3WT, C31S, and C150S in 293T
cells. Figure 2F (Supplementary Slide S2F) shows that the
FOXO3-PRDX1 oligomer can be detected with wild-type
FLAG-FOXO3, but not with single cysteine FOXO3mutants.
As FOXO3C31 and FOXOC150 are important for PRDX1
binding, we next examined how cysteine mutant FOXO3
activities were responding to PRDX1-mediated decrease
under H2O2-induced stress. Using a dual-luciferase reporter
assay, we observed that under lower H2O2 treatments PRDX1
is able to decrease FOXO3 activity significantly, and under
higher H2O2 doses (250lM), PRDX1-induced decrease of
FOXO3 was abrogated (Fig. 2G). In addition, PRDX1 did not
further decrease FOXO3 C31 or C150 activity, nor did higher
H2O2 doses increasemutant activity (Fig. 2H, I). In contrast to
wild-type FOXO3, PRDX1was unable to lower FOXO3 (DC)
luciferase activity (Supplementary Fig. S2B).
FOXO3 disulfide bonding with PRDX1 determines
subcellular localization under H2O2 stress
Several lines of evidence demonstrate that FOXO proteins
translocate to the nucleus under increased levels of ROS,
reviewed in Ref. (16). Importantly, nuclear localization of
FOXO proteins is a prerequisite for their transcriptional ac-
tivity, as such FOXOs are highly regulated through mecha-
nisms that alter nucleocytoplasmic shuttling (17). To address
if the PRDX1-FOXO3 disulfide bound complex influences
FOXO3 protein nuclear localization, we expressed WT-,
C31S-, or C150S-FOXO3-EGFP reporter constructs in 293T
cells and quantified nuclear localization following H2O2 ex-
posure for 1 h. Figure 3A and Supplementary Figure S3A
show that unlike WT FOXO3, C31S- and C150S-mutant
FOXO3s fail to translocate to the nucleus, even during a high-
dose H2O2 treatment. These data indicate that FOXO3 C31
and C150 regulate FOXO3 nuclear translocation. A well-
known mechanism regulating FOXO3 nuclear localization is
phosphorylation on T32 by AKT, which sequesters FOXO3
in the cytosol (6). We therefore examined the AKT phos-
phorylation status of C31S and C150S FOXO3 mutants.
Figure 3B (Supplementary Slide S3B) shows that FOXO3
WT T32 phosphorylation levels were increasing following
treatment with H2O2, which corresponded with binding of
14-3-3 to the PRDX1-FOXO3 complex (Supplementary
Fig. S3B and Supplementary Slide S3B). Interestingly, both
mutants showed increased basal levels of T32 phosphoryla-
tion compared to FOXO3 WT, with phosphorylation further
increasing with additional H2O2 treatment. We also exam-
ined phosphorylation at S318, another AKT phosphorylation
site known to enhance FOXO3 nuclear export (48), and found
no change in phosphorylation levels between FOXO3 WT
and the C31S and C150S single FOXO3 mutants (Supple-
mentary Fig. S3C and Supplementary Slide S3C), suggesting
the binding of PRDX1 to FOXO3 has a site-specific effect on
FOXO3 phosphorylation. Given that FOXO3 C31S and
C150S mutants have increased T32 phosphorylation and
dysfunctional translocation in response to high doses of H2O2
(Fig. 3A, B), we questioned if PI3K inhibition is capable of
promoting FOXO3 C31S and C150S mutant nuclear trans-
location. To do so, we applied experimental conditions that
would decrease the activation of kinases such as STK4/
FIG. 4. FOXO3 consensus binding se-
quence found in let-7b and let-7c pro-
moter region. (A) Putative FOXO3 binding
sequence (10). (B) Putative FOXO binding
motifs in forward and reverse are located in
the 5¢ UTR of let-7b and -7c in several
species. The consensus FOXO binding se-
quences in the WebLogo (black boxes) are
indicated. Numbering is relative to the
transcription start site obtained through the
University of California Santa Cruz Genome
Browser. UTR, untranslated region.
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MST1, JNK, and p38 (23, 31), known to induce FOXO3
nuclear localization by phosphorylating FOXO3. For exam-
ple,MST1 phosphorylation on FOXO3 is known to overcome
its AKT-induced cytoplasmic retention by decreasing 14-3-3
binding to FOXO3 (31). EGFP-FOXO3 localization was
compared in 293T cells treated with 100lMH2O2 for 30min.
Under this treatment, 14-3-3 binding to FOXO3 was not de-
creased (Supplementary Fig. S3B). In addition, as FOXO3
nuclear localization is dependent on DNA concentration
(Supplementary Fig. S3D), we assessed EGFP-FOXO3 local-
ization of 50ng of EGFP-FOXO3 in a subconfluent population
of cells to ensure AKT activity toward FOXO3 (26).We found
that LY294002 (PI3K inhibitor) treatment significantly in-
creased nuclear localization by 5.7%, 11.7%, and 25% in
FOXO3WT, FOXOC31S, and FOXOC150C, respectively,
compared to untreated cells (Fig. 3C, D). These results
FIG. 5. FOXO3 regulates expression of let-7 miRNAs under H2O2. (A) Overexpression of FLAG-FOXO3 enhanced
let-7b and c transcription in Hela cells 48 h after transfection. Cells were harvested, lysed, and analyzed for miRNA
expression by TaqMan assays, using the delta CT method with mir-30c as the internal standard. (B, C) FOXO3-deficient
HeLa cells were nonresponsive to H2O2 treatment. Thirty hours following transfection of shGFP or shFOXO3, cells were
treated with or without H2O2 for 18 h. Expression profiles of let-7b and let-7c were assessed by individual TaqMan assays
with U18 as the internal standard (N = 3). (D) ChIP assays indicate transfected FLAG-FOXO3 binds to the MIR99AHG and
intronic let-7c promoter regions and is enhanced following 100lM H2O2 treatment for 30min in 293T cells. Quantification
of immunoprecipitated DNA was performed in triplicate by quantitative PCR and evaluated by the delta CT method. Values
of each immunoprecipitated sample are expressed as a percentage relative to their respective input (no antibody). (E–G) let-
7b and c transcription was increased in PRDX1-deficient cells. HeLa cells were transfected with either a shGFP or
shPRDX1 construct for 56 h, followed by treatment with or without H2O2 for 18 h. HeLa cells were analyzed for gene
expression by TaqMan expression assays using the delta CT method with U18 as the internal standard (F, G) or b-actin as
the internal standard (H).
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suggest again that AKT-induced phosphorylation of
FOXO3 sequesters FOXO3 cysteine mutants in the cytosol.
Loss of PRDX1 enhances FOXO3-dependent
H2O2-induced let-7 miRNA upregulation
As prior studies have reported, increased let-7 family
member expression is induced by ionizing radiation, geno-
toxic stress, and peroxide (52, 53). In Caeorhabditis elegans,
let-7 family members have overlapping functions with
FOXO proteins to regulate development, aging, glucose
metabolism, stress responses, and act as tumor suppressors
(5). We were interested to examine if let-7 miRNAs are
regulated by FOXO3 under oxidative stress. Using the Uni-
versity of California Santa Cruz Genome Browser, we ana-
lyzed the 5¢ untranslated region (UTR) of let-7b and let-7c in
several species for putative FOXO3 binding sequences
(YTXXACA) (10). As shown in Figure 4A and B, FOXO3
binding sites are preserved in the 5¢ UTR of MIRLET7B and
MIRLET7C.
To confirm let-7 miRNAs as a potential novel FOXO3
target, we established that H2O2 treatment of HeLa cells
enhanced the expression of both let-7b and let-7c miRNAs
(Supplementary Fig. S4A). To determine if FOXO3 is in-
volved in H2O2-mediated enhanced expression of let-7b and
let-7c in HeLa cells, we performed either an overexpression
or a shRNA-mediated knockdown of FOXO3 before treat-
ment with H2O2. When FOXO3 expression increased, levels
of let-7b and let-7c were threefold and twofold higher, re-
spectively (Fig. 5A and Supplementary Fig. S4B). As FOXO3
expression was significantly diminished, the ability of H2O2
to induce either let-7b or let-7c miRNA expression was
lost (Fig. 5B, C, and Supplementary Fig. S4C). As a final
confirmation of FOXO3s role in the H2O2-mediated en-
hancement of let-7 expression, a chromatin IP (ChIP) assay
was performed showing that FOXO3 binds directly to both of
the let-7c promoter regions, the distal host gene and the
proximal intronic promoter, both considered functional in let-
7c transcription (44) (Fig. 5D and Supplementary Fig. S4D).
FOXO3 promoter binding was further enhanced following
FIG. 6. Lack of PRDX1
enhances levels and func-
tion of let-7 miRNAs under
H2O2. (A) Mirlet7 expres-
sion in normal and breast
cancer tissue from TCGA.
(B) Expression of FOXO3
and PRDX1 from TCGA
breast cancer cases and nor-
mal tissue was compared to
Mirlet7c expression. (C) EV
or shPRDX1 MDA-MB-453
cells were harvested, lysed,
and analyzed for miRNA ex-
pression by TaqMan assays
using the delta CT method
with U18 as the internal
standard (N= 3). (D–E)
Wound healing was increased
following let-7 inhibition in
PRDX1-deficient breast can-
cer cells. 1· 106 shPRDX1
MDA-MB-453 or MCF-7
(white bar) cells or control
(black bar) cells were trans-
fected with a let-7 miRNA
inhibitor in a 12-well plate
and wound healing was as-
sessed after 48 h (MDA-MB-
453) or 24 h (MCF-7) in the
presence of mitomycin C
(0.5lg/ml). Wound area of
let-7 inhibitor-treated cells
was normalized to control
miRNA inhibitor-treated
cells (mean + SE) N= 4.
Right side, representative
photographs of wound heal-
ing assays in MDA-MB-453
or MCF-7 cells. TCGA, The
Cancer Genome Atlas.
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100 lMH2O2 treatment compared to no treatment. These data
suggested that FOXO3 very likely regulates the expression of
MIRLET7B and MIRLET7C. Next, we examined if loss of
PRDX1magnifies let-7miRNA transcription in the context of
H2O2 addition. Figure 5E and F show when PRDX1 expres-
sion was more than 90% reduced (Supplementary Fig. S4E),
let-7b and let-7c expression levels were augmented. This
effect was further enhanced with 100lM H2O2 treatment.
Moreover, SOD2, an established target of FOXO3, was also
increased on H2O2 treatment in the context of PRDX1
knockdown (Fig. 5G). In conclusion, these data suggest that a
PRDX1/FOXO3 signaling axis exists that directly regulates
let-7c expression under H2O2-induced stress.
The PRDX1-FOXO3-let-7 axis regulates breast
cancer cell migration
Finally, we sought functional confirmation of the PRDX1-
FOXO3-let-7 axis. As genetic alterations in cancer cells
elevate the production of ROS, reviewed in Ref. (43) and let-
7b and let-7c suppress cancer development (5), including
breast cancer (13, 59, 65), we compared let-7c expression
levels in normal and breast cancer cases (8). We found let-7c
expression to be significantly lower in breast cancer tissues
compared to normal breast tissue (Fig. 6A). FOXO3 showed
a similar expression pattern to let-7c, while PRDX1 ex-
pression was increased in breast cancer compared to normal
tissue (Supplementary Fig. S5A, B). Comparing changes to
PRDX1 and FOXO3 expression in normal and breast can-
cerous tissues using Pearson correlation demonstrated a
significant negative correlation for PRDX1 and FOXO3 in
this data set downloaded from GEO Accession: GSE62944
(47) (Fig. 6B), suggesting functional significance of our
findings. This was further substantiated analyzing breast
cancer patient survival in data sets from the Kaplan–Meier
Plotter (21) and the Gene Expression-based Outcome for
Breast Cancer Online (GOBO) (18), which showed that a
lower expression of FOXO3 and a higher expression of
PRDX1 correlate with shortened patient survival (Supple-
mentary Fig. S5C–F).
FOXO3 suppresses cancer development in different ways,
including the inhibition of cell motility (2, 4, 34, 40, 55, 56).
In contrast, while PRDX1 prevents cancer initiation (37, 38),
its role in cancer is less understood. Interestingly, we have
previously shown that PRDX1 deficiency in MCF-10A,
MCF-7, and MDA-MB-231 cells increased p38 activation
(61), which induces FOXO3 nuclear localization in MCF-7
cells (12, 23). We therefore hypothesized that inhibition of
let-7b and let-7c would affect migration differently in breast
cancer cells (MDA-MB-453 or MCF-7) with knockdown of
PRDX1 (shPRDX1) (Supplementary Fig. S5G and Supple-
mentary Slide S5G) compared to control vector treatment.
Intriguingly, cells with reduced PRDX1 showed a 30%
increase in let-7 expression (Fig. 6C) and a 50% (MDA-MB-
453) and a 30% (MCF-7) increased wound closure, respec-
tively, when transfected with single-stranded RNA oligonu-
cleotide inhibitors that compete with let-7b and let-7c seed
sequences (Fig. 6D, E). However, when compared with a
negative control single-strand RNA oligonucleotide, we saw
little to no wound closure between the control and shPRDX1
cells. Altogether, these data demonstrate that a PRDX1 reg-
ulated signaling axis exists in breast cancer and is required for
FOXO3 and let-7 miRNA upregulation to suppress breast
cancer cell migration.
Discussion
H2O2 is an important second messenger in cell signaling,
where it can directly induce oxidation of cysteine sulfhydryl
groups in proteins, thereby impacting protein activity and
facilitating rapid signal transfer comparable to other post-
translational modifications (49). Thus, oxidative equivalents
can be passed on by H2O2-scavenging enzymes such as
peroxidases (50). This reaction entails a transient disulfide
exchange reaction between cysteine thiols, which requires
close proximity of the peroxidase with a partnering protein
(20). Peroxiredoxins have been suggested to form disulfide
bridges with partnering proteins to pass oxidizing equivalents
this way, thereby modulating protein activity of their binding
partners (28, 57). Our data suggest a similar mechanism be-
tween PRDX1 and the transcription factor FOXO3. As the
disulfide exchange reaction is transient, capture of stable
complexes by co-IP is low as demonstrated by weak PRDX1
staining FLAG-FOXO3 pull down experiments despite the
high abundance of PRDX1 in cell lysate (Fig. 1B, C).
FOXO family members have been implicated in ROS sig-
naling involving cysteine thiols. For example, a recent study
showed p300 to form disulfide reactions with FOXO4 that
result in its acetylation and nuclear localization (14). However,
more examples are needed to fully understand specific roles of
FOXO proteins in redox response. We present for the first
time, evidence of an H2O2-dependent regulation of FOXO3
activity directly through the oxidative stress-signaling sensor
PRDX1. Our data suggest the formation of a disulfide bond
between a PRDX1 dimer and FOXO3 monomer involving the
PRDX1 peroxidatic and resolving cysteines C52 and C173,
respectively, as well as C71. In FOXO3, the FOXO3 C31 is a
shared cysteine among FOXO family members, while C150 is
unique to FOXO3, suggesting a redox regulation that is spe-
cific for FOXO3 (Fig. 2). We further show the importance of
PRDX1-FOXO3 binding by demonstrating increased FOXO3
cytoplasmic sequestration (Fig. 3A) due to increased AKT
phosphorylation of FOXO3 mutants impaired in PRDX1
binding after H2O2 treatment (Fig. 3B–D). However, a
further delineation of the FOXO-PRDX1 signaling pathway
is warranted to determine the role that other family members
may play, as a recent proteomic profiling report found that
PRDX1, 2, and 5 are cysteine-dependent binding partners of
FOXO3 and suggested that competition among PRDX
family members may be present for FOXO3 binding (45).
We show that the PRDX1-FOXO3 complex formed in the
presence of elevated H2O2 is a cysteine-dependent oligomer.
A unique property to the PRDX1-FOXO3 axis is the utili-
zation of C150 of FOXO3, which is exclusive to FOXO3,
suggesting specificity of the PRDX1-FOXO3 interaction.
Mutation of C31 or C150 inhibits FOXO3 complex for-
mation with PRDX1 and renders these FOXO3 mutants
unresponsive to oxidative insult, exhibiting cytoplasmic
accumulation, which suggests PRDX1 binding of FOXO3
via disulfide bonds is critical for regulating FOXO3 in re-
sponse to oxidative stress (Figs. 2 and 3). Luciferase reporter
assays indicated FOXO3 becomes unresponsive to PRDX1-
induced control following treatment with high doses of H2O2
(Fig. 2G–I), suggesting over-oxidation of PRDX1 impairs
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FOXO3 binding and may also allow FOXO3 posttranslational
modifications to induce nuclear translocation (Fig. 1E).
FOXO3 C31 or C150 mutants (Fig. 3C, D) were unresponsive
toPRDX1 regulation, but surprisingly correlatedwith cytosolic
sequestration underH2O2-induced stress (Fig. 3A) compared to
FOXO3WT. To determine why FOXO3 C31S and C150S
mutants could not bind PRDX1, but were sequestered from the
nucleus (Fig. 3A), the phosphorylation status of FOXO3 T32
and S318, which represses FOXO3 through AKT and SGK
signaling (7), was probed. Interestingly, wild-type FOXO3
showed an H2O2-dependent increase in T32 phosphorylation,
however, FOXO3 cysteine mutants displayed much higher
phosphorylation. FOXO3C31S showed an overall higher
phosphorylation of T32, while FOXO3C150 T32 phosphory-
lation was higher than FOXO3WT but not as responsive to
H2O2 stimulation (Fig. 3B). Analysis of S318 phosphorylation,
however, showednodifferencebetweenwild-type FOXO3and
the FOXO3 cysteine mutants (Supplementary Fig. S3C), sug-
gesting that PRDX1 binding to FOXO3 is site specific and
calibrates T32 phosphorylation, but not S318.
FOXO3 nuclear localization is regulated by AKT and SGK
phosphorylation inducing 14-3-3 binding and cytoplasmic
sequestration or kinases that induce nuclear localization. Can-
didate kinases include MST1, JNK, or p38 (19, 23) (Fig. 7),
where MST1 can induce nuclear localization of an AKT
phosphorylated FOXO3 protein (31). Interestingly, all three
kinases are subject to PRDX1 binding and subsequent regula-
tion, indicating another layer of control in the PRDX1/FOXO3/
let-7c axis that requires future analysis. We suspect that under
high oxidative stress, MST1, an essential activator of FOXO
and repressor of AKT (11, 31), is activated by PRDX1
decamers (formed by 10 over-oxidized PRDX1 proteins)
(35) under higher oxidative stress causing phosphorylation
of FOXO3 on S207. This suggests that FOXO3 nuclear lo-
calization under H2O2-induced stress may increase in the
presence of decameric (over-oxidized) PRDX1. This is in
alignment with our findings that PRDX1 binding to FOXO3
does not include over-oxidized PRDX1 protein (Supple-
mentary Fig. S1A) and is dynamic as it decreases after
30min in H2O2-treated cells (Fig. 1C). On the contrary,
kinase activity of JNK and p38 is inhibited by PRDX1,
perhaps accounting for the increased localization of FOXO3
in the nucleus in PRDX1-deficient cells compared to PRDX1-
proficient cells (Fig. 1E and Supplementary Fig. S1C). This
suggests different roles for PRDX1 on FOXO3 signaling and
needs further exploration in future studies. Further explor-
ing our findings that PRDX1 binding to FOXO3 calibrates
FOXO3 nuclear translocation through modulating AKT
phosphorylation, we demonstrate that PI3K inhibition rescued
translocation of C31S and C150S mutant FOXO3 to FOX-
OWT levels following H2O2 exposure (Fig. 3C, D).
Collectively, these data suggest an oxidative stress-
dependent mechanism of FOXO3 cytoplasmic loading, a
protection and release that are directed through PRDX1 by
binding to FOXO3 and coordinating its posttranslational
modifications (Fig. 7). Accordingly, PRDX1-dependent
protection of FOXO3 from repressive phosphorylation and
degradation pathways would enable a FOXO3 reservoir not
reliant on de novo synthesis of FOXO3 or T32 dephosphor-
ylation. The PRDX1-FOXO3 axis therefore is more than
simply an inhibitory pathway, but rather, a redox-dependent
signaling modulator enabling controlled bursts of FOXO3
nuclear translocation and gene expression. Based on our data
shown here, we propose that PRDX1 builds a stepwise and
redox-dependent FOXO3 cytoplasmic reservoir that is read-
ily available once high H2O2 levels stimulate FOXO3 nuclear
function (Supplementary Fig. S6).
miRNAs are direct targets of transcription factors that are
known as important tumor suppressors or oncogenic proteins.
Yet, remarkably little is understood of miRNAs that are re-
sponsive to FOXOs. Consensus FOXO DNA binding motifs
are present in the 5¢ UTR of let-7b and let-7c in several
species (Fig. 4). Interestingly, let-7b and let-7c-2 in Mus
musculus and Rattus norvegicus are located in tandem and
separated by 621 and 319 nucleotides, respectively. Our re-
sults establish for the first time that let-7b and let-7c are
upregulated by FOXO3 (Fig. 5) directly to both of let-7c
promoter regions (the distal host gene and the proximal in-
tronic promoter) considered functional in let-7c transcription
(44) (Fig. 5D and Supplementary Fig. S4D). In addition,
FIG. 7. Model: stepwise oxidation of PRDX1 regulates FOXO3 under oxidative stress. PRDX1 and FOXO3 interact
in an oxidative stress-dependent way. This involves the catalytic/peroxidatic cysteine and C71 of PRDX1 and C31 and C150
of FOXO3. Our data strongly suggest disulfide bonding between PRDX1 and FOXO3 involving PRDX1 C52, C71, and
C173 and FOXO3 C31 and C150 regulating the AKT-induced phosphorylation of T32 on FOXO3 and 14-3-3 binding and
dissociation. Nuclear localization and 14-3-3 dissociation of FOXO3 may be promoted by monoubiquitination or phos-
phorylation by over-oxidized PRDX1 activating MST1 or oxidative stress activation of JNK or p38. This results in
expression in let-7b and let-7c and inhibition of migration.
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FOXO3 promoter binding is enhanced following 100lM
H2O2 treatment compared to no treatment (Fig. 5D). These
data define a new facet of FOXO3-mediated responses to
oxidative stress, as our findings are consistent with prior re-
ports that show let-7 members are upregulated by ionizing
radiation, genotoxic stress, and peroxide (52, 53). Intrigu-
ingly, we identified a novel FOXO3 target with direct tumor
suppressive activity, as let-7 miRNAs bind to 3¢ UTRs of
target oncogenes and cell cycle regulators and that reduced
let-7 expression has been shown to correlate with the de-
velopment of cancers (64).
Systemic deletion of FOXOs results in cancer in murine
models in vivo, underscoring their role as bona fide tumor
suppressors (42). In addition, inactivating genetic mutations
and reduced expression of FOXOs occur in human cancers (3,
24), and suppression of FOXO function is critical in pro-
moting evasion of apoptosis and is a significant occurrence in
several hematological malignancies, including Bcr-Abl+
leukemia (17, 27). Notably, a more specific role has been
identified for FOXO3 as an inhibitor of cancer cell motility
(40, 56) and wound healing (51), suggesting that FOXO3
may regulate cell motility.
Similar to FOXOs, PRDX1 protects from tumor initiation
(38), however, in contrast to FOXO3, several reports indicate
poor prognosis for cancers with high expression of PRDX1
(29, 58, 67). This is in line with The Cancer Genome Atlas
and survival analyses showing PRDX1 expression elevated
in breast cancer patients with decreased survival (Fig. 6B and
Supplementary Fig. S5C–F). Importantly, these data support
our findings that a PRDX1-FOXO3-let-7 axis exists in tu-
morigenesis. Furthermore, PRDX1-deficient MDA-MB-453
cells showed increased levels of let-7c (Fig. 6C) and let-7
inhibition increased cell motility of MDA-MB-453 and
MCF-7 breast cancer cells, both of which show lowmotility (1),
with decreased PRDX1 expression (Fig. 6D, E). This finding is
consistent with earlier studies showing that let-7 miRNAs in-
hibit motility of breast cancer cells by regulating genes in the
actin cytoskeleton pathway (25). Given the findings of these
studies and those presented here, it would be interesting in fu-
ture studies to determine let-7miRNA targets that are controlled
by PRDX1 and FOXO3 in cancer development.
The free radical theory of aging posits that accumulated
damage from oxidative events shortens life span. The fun-
damental importance of PRDX1 in protecting from the del-
eterious effects of oxidative stress is best illustrated by the
multiple cancers and shortened life span in Prdx1-deficient
mice (38). Moreover, hyperactivation of FOXO proteins has
been implicated in extending life span (63). Our data suggest
that FOXO3 fine tunes cellular homeostasis in response to
cellular redox through integration with PRDX1. Because
ROS are fundamental in driving the aging process and in the
development of cancers, this new mechanism we describe
here adds to our understanding of how the evolutionarily
conserved FOXO C31 in conjunction with C150 may be in-
strumental in the regulation of aging and tumor suppression.
Materials and Methods
Cell culture
293T (HEK 293T) and HeLa cells were obtained from
ATCC. These cells were grown in DMEM (Mediatech)
supplied with 10% heat-inactivated FBS (HyClone), 100U/ml
penicillin, 100mg/ml streptomycin (Mediatech), and 2mM
l-glutamine (Mediatech) (complete DMEM) in a 37C in-
cubator supplied with 5% CO2. Prdx1
+/+ and Prdx1-/- MEFs
were generated as described in Ref. (9) from Prdx1 knockout
and parental mice (38) and grown in the same conditions as




FOXO3, and pcDNA3-FLAG-HA-FOXO3 have previously
been described (54). Site-directed mutagenesis of FOXO3
plasmids was performed using the Stratagene QuikChange II
XL kit (Agilent Technologies) following the manufacturer’s
guidelines. The oligonucleotides used were designed using
the online QuikChange Primer design application (Agilent
Technologies) and were synthesized from Integrated DNA
Technologies. The pcDNA3-FLAG-HA-FOXO3 plasmid
was used as a template to generate all five single C-to-S
mutants. Each clone obtained was sequenced with four dif-
ferent sequencing primers to span, with overlaps, the entire
coding sequence. To generate the double, quadruple, and
quintuple C-to-S mutants, newly synthesized single Cys-to-
Ser mutants were used as templates for successive muta-
genesis rounds with full-length sequencing after each round.
To generate the Cys-to-Ser mutants of pcDNA3-FLAG-
FOXO3, the inserts of the several C-to-S mutants of
pcDNA3-FLAG-HA-FOXO3 were excised with a BamH1-
Xho1 (New England Biolabs) restriction enzyme digestion
and cloned into the pcDNA3-FLAG-FOXO3 plasmid, also
digested with BamH1 and Xho1 to remove the unmutated
FOXO3 insert. shRNA for FOXO3 (NM_001455.x-2766s1c1
clone) was purchased from Sigma. shPRDX1 expression
constructs were used as previously described (61).
FOXO3–H2O2 dosage
HEK 293T cells (5 · 105) were transiently transfected with
2 lg pcDNA3-FLAG-HA (EV) or pcDNA3-FLAG-FOXO3
plasmids, using the FuGENE 6 system for 48 h. Cells were
serum starved for 30min and then treated with 0, 25, 100, 250,
or 500lM H2O2 for 30min. Samples were lysed using a tris
lysis buffer (50mM Tris; 2% Triton X-100; 0.5mM EDTA;
0.5mM EGTA; 150mM NaCl; 10% glycerol; 50mM NaF;
1mM NaVO4; 40mM b-glycerophosphate), supplemented
with 30lg/ml catalase from bovine liver (Sigma), and pro-
teinase inhibitors. Protein concentrationswere quantified using
the Pierce BCA Protein Assay kit, according to the manufac-
turer’s instructions (Thermo). One milligram of cell lysate was
incubated with 20ll of acid-treated Anti-FLAG M2 Affinity
Gel (Sigma) and 400ll lysis buffer, at 25C for 3 h, with
rotation. Precipitated samples were collected and washed four
times with lysis buffer and once with 1·TBS. Beads were
boiled in Laemmli sample buffer (BioRad) in the presence or
absence of b-mercaptoethanol (Sigma) for 10min. Twenty
micrograms of whole cell lysate input was prepared in
Laemmli sample buffer as above for 5min.
FOXO3 C-to-S mutant transfection
HEK 293T cells (5 · 105) were transiently transfected with
2 lg EV, pcDNA3-FLAG-FOXO3, or pcDNA-FLAG-HA-
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FOXO3 constructs containing various C-to-S mutations,
using the FuGENE 6 system for 48 h. Cells were serum
starved for 30min and then treated with 0 or 25lM H2O2.
Samples were lysed using the tris lysis buffer detailed above,
supplemented with 30lg/ml catalase from bovine liver (Sig-
ma), and proteinase inhibitors. Protein concentrations were
quantified using the BCA protein assay (Thermo). IP of
1000lg (or 1500lg for nuclear localization) of cell lysate was
processed as detailed above.
PRDX1 C-to-S mutant transfection
HEK 293T cells (5· 105) were cotransfected with pcDNA-
FLAG-FOXO3 and pcDNA3-HA-PRDX1 or pcDNA3-HA-
PRDX1 constructs containing various C-to-Smutations using
the FuGENE 6 system for 48 h. Cells were serum starved for
30min and then treated with 0 or 25 lM H2O2. IP samples
were prepared as above with 1.5mg of cell lysate for relative
protein quantification.
FOXO3-PRDX1 interaction in MEFs
Confluent Prdx1+/+ and Prdx1-/-MEFs were serum starved
for 30min and then treated with 0, 25, or 250lM H2O2 for
30min. Cells were lysed in the aforementioned tris lysis buffer
and 80lg of cell lysate was used for relative protein quanti-
fication.
Western blotting
Prepared IP samples and corresponding whole cell ly-
sates were fractionated by SDS-PAGE and transferred to a
nitrocellulose membrane according to the manufacturer
(BioRad). Membranes were blocked with 5% BSA in TBS
for 30min and incubated with antibodies against FOXO3
(1:1000; Abcam), P-FOXO3 T32 (1:1000; Cell Signaling),
PRDX1 (1:4000; Abcam), PRDX-SO3 (1:500; Abcam), 14-
3-3 (1:1000; Cell Signaling), or actin (1:1000; Oncogene)
overnight at 4C. Membranes were washed four times for
5min in TBST (0.05% Tween-20) and visualized by IR or
chemiluminescent detection. For IR processing, mem-
branes were incubated with a 1:15,000 dilution of anti-goat,
anti-rabbit, or anti-mouse IRDye (LI-COR) for 30min at
25C. Blots were washed with TBST three times and with
TBS once, and imaged on an Odyssey (LI-COR) imager.
Membranes processed by chemiluminescence were incu-
bated in a 1:10,000 dilution of HRP-conjugated anti-mouse
or anti-rabbit antibodies for 1 h at 25C. Blots were washed
four times with TBST for 5min and exposed to ECL for
1min.
FOXO3 nuclear localization in 293T cells
Nuclear localization of 5.0 · 104 293T cells transiently
transfected with FuGENE 6 for 24 h with 50 ng EGFP-
FOXO3 or FOXO3-EGFP C31S or C150S mutants, trans-
ferred to complete media for 24 h, serum starved for 1 h, then
treated with 100lMH2O2 or vehicle and 20lMLY294002 or
vehicle for 30min, fixed with 2% paraformaldehyde for
15min, and quantified by blinded scoring of triplicate images
from three separate experiments using a IX83 microscope
(Olympus).
FOXO luciferase assay
FOXO signaling activity was quantified in mouse embry-
onic fibroblasts or HEK 293T cells utilizing the dual-
luciferase Cignal FOXO Luciferase Reporter assay (Qiagen).
2.5 · 105 MEFs were transiently cotransfected with 350 ng
Cignal reporter plasmids, 0.5 lg of PRDX1 and FOXO3 or
FOXO3 cysteine mutant plasmids, and compared to FOXO3
plus vector control samples. Transfections were performed
with FuGENE 6 for 24 h. Luciferase activity was normalized
to the internal Renilla control. The effect of oxidative stress
on FOXO3 activity was quantified in 293T cells by trans-
fection with 350 ng Cignal reporter plasmid, 50 ng FOXO3,
or the FOXO cysteine mutants. Five hundred nanograms of
PRDX1 was transfected into the cells 8 h later and incubated
for an additional 14 h. Luciferase activity was measured 1.5 h
following 30min of 0–250 lM H2O2 treatment. Dual-
luciferase activity was measured in 1· passive lysis buffer
using the manufacturer’s protocol (Promega).
Endogenous transcript quantification in 293T cells
293T cells (2.5 · 105) infected with pLKO.1 control or
shPRDX1 plasmids were serum starved for 1 h and then
treated with 0 or 250 lM H2O2 for 16 h. RNA was isolated
utilizing the GeneJET RNA Purification Kit (Thermo Sci-
entific) and converted to cDNA with the qScript cDNA
synthesis kit (Quanta Biosciences). SESN3, P27, BIM,
SOD2, CAT, and P21 transcripts were quantified by SYBR
green real-time PCR (BioRad) relative to YWHAZ control
using custom primers (Supplementary Table S1) and ac-
counting for PCR efficiency.
Quantitative real-time-qPCR
Cell lysates were generated with the Cells-to-CT kit (Life
Technologies). RT enzymes, individual TaqMan assays, and
all PCR enzymes, dyes, and buffers were purchased from Life
Technologies and used according to the manufacturer’s
suggestions. All qPCRs were run on an ABI 7900HT in-
strument.
Cell viability assay
HEK 293T cells (5· 105) were transiently transfected with
2 lg pcDNA3-FLAG-FOXO3 plasmids, using the FuGENE
6 system for 24 h. Cells were then trypsinized and then
2 · 104 cells were plated into the wells of a 96-well assay
plate. The next day, the cells were treated with 0, 250, or
500 lM H2O2 for 3 h. Viability, cytotoxicity, and apoptosis
were then measured using the ApoTox-Glo Triplex Assay
(Promega), following the manufacturer’s protocol.
Wound healing assay
One million MDA-MB-453 cells were infected with a
pLKO.1 shPRDX1 or control construct and then transfected
in a 12-well plate with 25 nM let-7 miRIDIAN microRNA
hairpin inhibitor (GE Dharmacon) or miRIDIAN microRNA
hairpin inhibitor negative control #1 (GE Dharmacon) and
25 nM siGLO Green Transfection Indicator (GE Dharmacon)
utilizing 5ll DharmaFECT 2 transfection reagent (GE
Dharmacon) per well. Confluent cultures were scratched with
a 10ll pipette tip in the presence of mitomycin C and
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photographed after 48 h to measure wound healing. Wound
area was quantified with the ImageJ plugin MRI Wound
Healing Tool (Volker Ba¨cker). let-7b expression was used as
an indicator of let-7 inhibition. The relative wound area was
compared in PRDX1-deficient cells and control cells treated
with the let-7 miRIDIAN inhibitor normalized to control
microRNA hairpin inhibitor. Average values were compared
from four separate experiments + standard error of the mean.
ChIP Assay
293T cells were seeded (4 · 106 cells/dish 150mm) and
24 h later transfected with EGFP-FOXO3 plasmid (14lg/
dish) by the calcium phosphate method. Forty-eight hours
after transfection, complete medium was replaced with
serum-free medium for 30min, followed by H2O2 (100lM)
treatment for 30min. Cells were crosslinked with 1% form-
aldehyde for 10min at 25C and then the reaction was
stopped by addition of glycine to a final concentration of
0.125 M. Crosslinked chromatin was immunoprecipitated
with 1lg of FOXO3 antibody (ab12162; Abcam) as previ-
ously described (44). The genomic regions in the host gene
and intronic promoter, close to FOXO3 binding sites, were
amplified with primers designed by the Primer-Blast NCBI
software (www.ncbi.nlm.nih.gov/tools/primer-blast). The
following primer sequences were used: MIR99HG oligo#1
FW: 5¢-CTATGCGCCACTCTGTGCAA-3¢; MIR99HG oli-
go#1 RV: 5¢-CTAATTACCGCGCACAAGCTG-3¢; let-7c
intronic prom oligo #2 FW: 5¢-GGCATAAACCCGTAGA
TCCG-3¢; let-7c intronic prom oligo #2 RV: 5¢-GAG
CTTGTGCGGTCCACTT-3. Quantification of cDNA was
performed in triplicate on an Applied Biosystems 7500 Real-
Time PCR System SDS v1,2, using the SYBR green dye
detection method. ChIP assay results were evaluated by the
double delta CT method.
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b-ME¼ beta-mercaptoethanol





EGFP¼ enhanced green fluorescent protein
ERp46¼ endoplasmic reticulum protein 46
FLAG¼ FLAG-epitope tag
FOXO¼ forkhead box transcription factors of
the O class
HA¼ human influenza hemagglutinin




MST¼mammalian sterile 20-like kinase 1
NEM¼N-ethylmaleimide
p21¼ cyclin-dependent kinase inhibitor1




qPCR¼ quantitative polymerase chain reaction
ROS¼ reactive oxygen species
SGK¼ serum and glucocorticoid-regulated kinase 1
sh¼ small hairpin
SOD2¼ superoxide dismutase 2




OXIDATIVE STRESS INDUCES THE PRDX1-FOXO-LET-7 AXIS 77
